Impact of Final Phase Social Isolation and the COVID-19 Pandemic on Eating Behavior, Sleep Quality, and Anxiety Level.

Publication date: Apr 29, 2023

The coronavirus disease 2019 (COVID-19) pandemic has resulted in economic, social, and behavioral changes in people, which may favor several long-term consequences. This study evaluated the effects of the COVID-19 pandemic on eating behavior and mental health in the final phase of social isolation. This cross-sectional study included 756 adults that completed an online questionnaire. Individuals were stratified into those who had been infected with COVID-19 (GCOV) and those who did not (GNCOV). The GCOV group had higher weight (p = 0. 013), body mass index (BMI) (p = 0. 005), anxiety levels (p = 0. 040), sleep disorders (p = 0. 009), and poorer sleep quality (p = 0. 0028). In the GCOV, the consumption of ultra-processed foods was associated with higher anxiety levels and poorer sleep quality. A higher proportion of individuals who consumed more than five servings of in natura food was observed in the group with taste and olfactory dysfunction than in the group without. Obesity contributes to uncontrolled and emotional eating disorders, increased anxiety, and worsened sleep. Therefore, COVID-19 impaired mental health and eating behavior even in the long term. These changes were potentiated by the presence of obesity and consumption of ultra-processed foods, evidencing the importance of monitoring these individuals even after the resolution of COVID-19.

Open Access PDF

Concepts Keywords
Coronavirus Adult
Eating Anxiety
Obesity anxiety level
Pandemic COVID-19
Cross-Sectional Studies
dietary habits
eating behavior
Feeding Behavior
Sleep Quality
sleep quality
Social Isolation


Type Source Name
disease MESH COVID-19 Pandemic
disease MESH Sleep Quality
disease MESH sleep disorders
disease MESH Obesity
disease MESH eating disorders
drug DRUGBANK Coenzyme M
disease MESH severe acute respiratory syndrome
disease IDO country
disease VO time
disease MESH infection
disease VO organization
disease MESH psychiatric disorders
disease MESH insomnia
disease MESH complications
disease MESH nutritional status
disease VO frequency
drug DRUGBANK Methionine
disease MESH education level
disease MESH marital status
disease MESH underweight
disease MESH weight gain
disease MESH overweight
drug DRUGBANK Angiotensin II
disease MESH lifestyle
disease VO population
disease MESH uncertainty
disease MESH chronic diseases
disease VO efficiency
disease IDO immune response
disease MESH anxiety disorders
disease MESH neuroinflammation
disease MESH reinfection
drug DRUGBANK Dextrose unspecified form
disease VO vaccinated
disease IDO intervention
disease VO protocol
disease MESH Binge Eating
drug DRUGBANK Efavirenz
disease MESH Psychological Distress
drug DRUGBANK Guanosine

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *